EDIT Q1 2019 Earnings — Editas Medicine, Inc. Revenue & Financial Results | Market Cap Arena

EDITEditas Medicine, Inc.

$260M

Q1 2019 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-47.3% YoY

Gross Profit

-$14M-665.7% margin

Operating Income

-$31M-1511.0% margin

Net Income

-$29M-1413.7% margin

EPS (Diluted)

$-0.60

QoQ Revenue Growth

-66.2%

Cash Flow

Operating Cash Flow

-$29M

Free Cash Flow

-$30M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$379M

Total Liabilities

$162M

Stockholders' Equity

$217M

Cash & Equivalents

$158M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$4M	-47.3%
Gross Profit	-$14M	-$17M	+20.7%
Operating Income	-$31M	-$32M	+0.9%
Net Income	-$29M	-$31M	+5.5%